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Summary. The human respiratory tract contains a highly adapted microbiota including commensal and opportunistic patho-
gens. Noncapsulated or nontypable Haemophilus infl uenzae (NTHi) is a human-restricted member of the normal airway micro-
biota in healthy carriers and an opportunistic pathogen in immunocompromised individuals. The duality of NTHi as a colonizer 
and as a symptomatic infectious agent is closely related to its adaptation to the host, which in turn greatly relies on the genetic 
plasticity of the bacterium and is facilitated by its condition as a natural competent. The variable genotype of NTHi accounts for 
its heterogeneous gene expression and variable phenotype, leading to differential host-pathogen interplay among isolates. Here 
we review our current knowledge of NTHi diversity in terms of genotype, gene expression, antigenic variation, and the pheno-
types associated with colonization and pathogenesis. The potential benefi ts of NTHi diversity studies discussed herein include 
the unraveling of pathogenicity clues, the generation of tools to predict virulence from genomic data, and the exploitation of 
a unique natural system for the continuous monitoring of long-term bacterial evolution in human airways exposed to noxious 
agents. Finally, we highlight the challenge of monitoring both the pathogen and the host in longitudinal studies, and of applying 
comparative genomics to clarify the meaning of the vast NTHi genetic diversity and its translation to virulence phenotypes. 
[Int Microbiol 2012; 15(4): 157-170]
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Introduction
 
The human upper respiratory tract contains a characteristic 
and highly adapted microbiota encompassing commensal 
microorganisms and opportunistic pathogens. The fi ne-
tuned balance of the microbial-airway interplay underlies 
normal lung function, but it can be altered by host genetic 
factors or immunological status, by host exposure to external 
factors such as radiation, infectious agents, chemical 
contaminants, and environmental pollutants, as well as by 
diet, lifestyle (e.g., tobacco or alcohol use), occupation, and 
medical interventions [70]. Regardless of their origin, the 
changing conditions often allow existing or newly acquired 
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opportunistic pathogens to modify their status as colonizers, 
becoming the cause of a symptomatic infection. Moreover, 
opportunistic pathogens often display high genetic plasticity 
as a strategy to drive continuous evolution, thereby facilitating 
the evasion of host immunity, carrier state colonization, or 
symptomatic infection. In this review, we focus on a member 
of the human airway microbiota, the opportunist pathogen 
nontypable Haemophilus infl uenzae (NTHi). We review the 
most recent knowledge on its genetic diversity and highlight 
questions and challenges for its future study with respect to 
heterogeneity, evolution, and host interplay. Although tailored 
to H. infl uenzae, our discussion is applicable to almost any 
other opportunistic pathogen.
 
General features of the bacterial res–
piratory pathogen Haemophilus infl u-
enzae
Haemophilus infl uenzae is a gram-negative coccobacillus 
whose environmental niche is primarily restricted to the 
human respiratory tract. It is classifi ed on the basis of its 
production of a polysaccharide capsule; strain types a–f 
produce antigenically distinct capsules while nontypable 
strains do not. The use of H. infl uenzae type b (Hib) conjugate 
vaccines has nearly eliminated invasive strains in places 
where the vaccines have been administered, but they have 
also promoted the emergence of NTHi strains as the most 
predominant of this pathogen species [1]. NTHi is a member of 
the human respiratory microbiota in most healthy individuals 
beginning in early life. Colonization by several different 
NTHi strains is often simultaneous [18], continuously 
renovated, and actively modulates colonization by other 
opportunistic pathogens such as Streptococcus pneumoniae 
[41,66]. In addition to colonizing the nasopharynx of healthy 
individuals, NTHi is an opportunistic pathogen. Colonization 
of the upper airways is also the fi rst step in the pathogenesis 
of NTHi infection, facilitated by contiguous spread of the 
bacteria and its migration from the nasopharynx to adjacent 
structures, including the sinuses, middle ear, trachea, and 
lower airways. Clinical manifestations of NTHi infection are: 
(i) upper respiratory tract involvement such as otitis media 
(OM) in children, as well as sinusitis, and conjunctivitis; (ii) 
exacerbations of conditions involving the lower respiratory 
tract (LRT) in adults suffering chronic obstructive pulmonary 
disease (COPD), as well as pneumonia and infections in cystic 
fi brosis (CF); and (iii) invasive disease, with bacteremia and 
meningitis as the most common presentations [1]. 
The notion that NTHi is highly adapted to the host is 
supported by the fact that this bacterium is: (i) human host-
restricted; (ii) successful at establishing a niche in the human 
airway as a colonizer; and (iii) provided with virulence 
factors facilitating the pathogen’s ability to take advantage 
of the host condition and cause a symptomatic infection. The 
adaptation of NTHi is manifested by wide variations in the 
DNA material among isolates. While encapsulated serotype 
type b invasive strains form a clonal group, there is enormous 
genetic heterogeneity among NTHi strains [25]. 
In general, existing evidence indicates that bacterial 
strains belonging to the same species vary considerably in 
gene content, and that the genetic repertoire of a given species 
is much larger than the gene content of individual strains. 
This has important consequences for our understanding of 
bacterial evolution, adaptation, and population structure, 
as well as for the identifi cation of virulence genes, vaccine 
design, etc. Bacterial species are currently described by their 
gene pools (pan-genomes or supra-genomes), which include 
a core genome containing genes present in all strains and an 
accessory or adaptive genome consisting of partially shared 
and strain-specifi c genes [47]. Available information on 
genotyping systems and genome sequencing of NTHi strains 
indicates that the pan-genome of this bacterial species is large 
[25,35]. The sources of selective pressure driving genetic 
diversity among populations of H. infl uenzae are likely related 
to the bacterial necessity to attach to host cells or surfaces for 
colonization, to evade host innate and adaptive immunity and 
persist in the host, to obtain iron and other nutrients essential 
for replication, and to disseminate or spread. 
Genetic mechanisms that modify H. infl uenzae gene 
content are: (i) the lateral transfer of DNA sequences 
between different bacterial cells, facilitated by the fact that 
NTHi is a naturally competent DNA acceptor [56]; (ii) 
genetic polymorphisms, encompassing gene point mutations, 
insertions, deletions, or duplications [25]; (iii) phase variation, 
a slipped-strand mispairing mediated by short DNA repeats 
(SSR, simple sequence repeats) in the coding or the upstream 
promoter regions of certain genes such that a spontaneous gain 
or loss of repeat units in these unstable regions either results 
in a translational frameshift or alters the distance spanned by 
the promoter, thus modifying gene expression [48]; and (iv) 
hypermutation [54]. 
Genetic variability is likely to have fundamental 
consequences in NTHi infection, favoring heterogeneous 
gene expression as well as phenotypic and antigenic diversity 
while providing this pathogen with strategies to evade host 
immunity and overcome antimicrobial treatment (Fig. 1). 
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NTHi genetic diversity: gene distribu-
tion/sequence conservation and 
genome-sequencing-based approaches
Haemophilus infl uenzae strain Rd KW20 was the fi rst free-
living organism from which a complete genome sequence was 
obtained, and the resulting information provided an excellent 
scaffold to assess H. infl uenzae diversity [19]. Nontypable 
strains of H. infl uenzae were long considered as colonizing 
bacteria whose virulence potential largely refl ected altera-
tions in host defenses. However, growing evidence based 
on NTHi recovered from disease states suggests that these 
bacteria are genotypically different, both in terms of disease 
state and compared to strains harvested from healthy carri-
ers [25,52,55,73]. These observations raise several questions: 
Can we identify genes/genomic regions important for NTHi 
virulence by comparing the genetic makeup of strains recov-
ered from disease with strains isolated from healthy carriers? 
Would this virulence-associated genetic material allow strain 
stratifi cation or the development of tools to predict NTHi 
virulence? The answers have been sought mainly by analyz-
ing the differential distribution of limited numbers of genes 
or genetic traits among NTHi isolates, and more recently, by 
comparative genomics of sequenced strains.
 
Gene distribution/sequence conservation among 
NTHi isolates. Explorations of NTHi genetic diversity 
have mainly been carried out using a reductionist approach, 
based on the survey of selected genes or genetic islands on 
isolate panels. The aim of these studies has been the identi-
fi cation of virulence factors, genetic markers for NTHi dif-
ferentiation from other bacteria, and useful epitopes as vac-
cine candidates. Gene distribution assessment has focused on 
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Fig. 1. Diagram of three different domains conferring diversity in Haemophilus infl uenzae: genetic variability, heterogeneous gene expression and phenotypic 
variability. The three diversity domains are intimately cross-related and lead to the generation of antigenic variation. Non-exhaustive examples of the available 
experimental evidence for each of these domains are provided.
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genes encoding NTHi surface molecules, including lipooligo-
saccharid (LOS) as well as adhesive and immunomodulatory 
molecules. Table 1 provides a list of genes that are variable on 
NTHi strains, and their sources of variability. 
The NTHi LOS is a glycolipid comprising a membrane-
anchoring lipid A linked by a single 2-keto-3-deoxyoctulosonic 
acid (Kdo) to a heterogeneous oligosaccharide (OS) composed 
of neutral heptose (Hep) and hexose (Hex) sugars, lacking an 
O antigen [60]. Each Hep of a conserved trisaccharide (HepI 
to HepIII) inner core can serve as a point for Hex addition 
and further chain extensions, the degree and pattern of which 
vary among strains [60]; a fourth heptose (HepIV) may be 
present on the OS extension from HepI [37] (Fig. 2). Several 
genes involved in LOS biosynthesis are variably present 
among H. infl uenzae strains. This is the case for li2BC 
and losAB [16,17,36]. The lic2C and lic2B genes encode 
glycosyltransferases responsible for initiating sugar extension 
from HepII [36] and for adding the second sugar (Glc or Gal) 
to the Glc on HepII, respectively [65]. The losB gene encodes 
a heptosyltransferase responsible for adding HepIV to the OS 
on HepI, and losA encodes another glycosyltransferase [37]. 
When present, lic2C is located in a genetic island fl anked by 
infA and ksgA. The infA-ksgA island can be absent, with the 
infA and ksgA adjacent to each other, or present, containing 
Table 1. Sources of genetic variability among noncapsulated Haemophilus infl uenzae strains
Gene Variable distribution Phase variation Allelic polymorphisms
lic2C Yes No ND*
lic2B Yes No ND
losAB Yes Yes, 5´-CGAGCATA in losA ND
lic3A No Yes, 5´-CAAT ND
lic3B Yes Yes, 5´-CAAT ND
lic1A Yes Yes, 5´-CAAT ND
lic1D Yes No Yes
lic2A No Yes, 5´-CAAT ND
lgtC No Yes, 5´-GACA ND
oafA No Yes, 5´-GCAA ND
lex2A Yes Yes, 5´-GCAA ND
lex2B Yes No Yes
hmw1A Yes Yes, 5´-ATCTTTC Yes
hmw2A Yes Yes, 5´-ATCTTTC Yes
hia Yes No Yes
hifABCDE Yes Yes, 5´-TA Yes
hap No No Yes
ompP5 No No Yes
oapA No No Yes
igaB Yes Predicted in strain 2019, 5´-AAATTCA Yes
*ND, not determined.
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(i) lic2C, (ii) lic2B and lic2C, or (iii) losA and losB [17]. A 
comparison between invasive NTHi isolates obtained from 
the host middle ear and nasopharynx/throat revealed that this 
island is present in most nasopharyngeal and OM isolates but 
absent from 40 % of invasive isolates [17]. 
A survey of lic2C from a collection of NTHi inner ear-OM 
isolates showed the presence of the gene in approximately half 
of the analyzed strains [36]. A later study from our laboratory 
on a panel of non-isogenic NTHi isolates of different 
pathological origin showed a 95 % prevalence of lic2C, 
suggesting that it encodes a molecular feature conferring 
bacterial fi tness during infectious processes [44]. Support for 
this observation comes from an analysis of lic2C distribution 
in a strain panel encompassing 54 NTHi strains collected 
from 20 adults suffering an underlying chronic respiratory 
disease. The patients were seen at a tertiary reference center 
(University Hospital Bellvitge, Spain) between two and fi ve 
times from 1996 to 2007. Strain molecular typing by pulse-
fi eld gel electrophoresis (PFGE) indicated a high diversity 
(45 PFGE different profi les). Patients were classifi ed as 
follows: Group A, consisting of 14 patients in whom each 
of the collected strains differed from the others with respect 
to the PFGE profi le; and Group B, consisting of six patients, 
among whom at least two of the strains collected per patient 
displayed the same PFGE profi le.
Collectively, lic2C was detected in 63 % of the isolates. 
Additional data from our laboratory suggested that lic2C 
is not necessarily linked to virulence, but, more generally, 
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Fig. 2. Model structure of NTHi lipooligosaccharide (LOS). A repertoire of modifi cations, whose presence and location are variable among strains, is shown. 
GlcN, glucosamine; Kdo, 2-keto-3-deoxyoctulosonic; PEtn, phosphoethanolamine; Hep, heptose; Glc, glucose; Gal, galactose; Neu5Ac, sialic acid; PCho, 
phosphorylcholine; OAc, O-acetyl group. Genes encoding enzymes responsible for the biosynthesis of the LOS molecule are indicated. Phase-variable genes 
are shown in white; non-phase-variable genes are shown in gray.
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to bacterial host adaptation. Evidence for this notion was 
obtained in an analysis of lic2C in a panel of 42 isolates 
encompassing 25 NTHi strains collected from 25 pediatric 
patients with OM (University Hospital Germans Trias i Pujol, 
Spain) and 17 NTHi nasopharyngeal isolates from 17 healthy 
children (University Hospital Bellvitge), in which the gene 
had a prevalence of 76 % and 94 %, respectively.
The linkage of lic2B with lic2C has been reported 
[17], with several studies addressing lic2B distribution and 
the gene’s prevailing presence in middle ear-OM isolates 
[55,71,73]. Our data on lic2B distribution within the panel 
of 42 NTHi pediatric strains described above confi rms an 
association between lic2B and lic2C, given that lic2B was only 
detected in lic2C-positive strains. Among OM patients and 
healthy carriers, the prevalence of lic2B was 56 % and 47 % , 
respectively; among the lic2C-positive isolates, the prevalence 
of lic2B was 73 % and 50 %, respectively. These data slightly 
differ from those previously reported, as the prevalence of 
lic2B among healthy carrier isolates was somewhat higher, 
which could be due to the origin, size, or nature of the strain 
panels. Nonetheless, they suggest the general involvement of 
lic2BC in NTHi-host interplay, rather than its exclusive role in 
virulence. Unlike lic2BC, the presence of losAB seems to be 
scattered, based on the gene’s detection in only three lic2BC-
negative strains in the same panel of 42 pediatric isolates. 
Similarly, a previous evaluation of losAB in two collections 
of NTHi clinical isolates yielded a prevalence of 16 % and 
18 %, respectively [16,17]. The phase variation of losA is an 
additional source of variability [16].
Sialylation, catalyzed by the sialyltransferases Lic3A, 
Lic3B, SiaA, and LsgB, is another variable modifi cation of 
NTHi LOS. Although the lic3A gene seems to be universally 
present, a survey of lic3B on a collection of NTHi inner-ear 
isolates identifi ed lic3B in 60 % of the strains [20]. However, 
a later study from our laboratory on a panel of non-isogenic 
NTHi isolates of different pathological origin showed the 
100 % prevalence of lic3B [44], and an assessment of the gene 
on the above-discussed panel of 42 pediatric isolates found a 
72 % and 100 % prevalence of lic3B among OM and healthy 
carriers, respectively. An additional source of variation in 
LOS sialylation is lic3A and lic3B phase variation [20]. 
The lic1 locus, encompassing the lic1ABCD operon, is 
responsible for the addition of phosphorylcholine (PCho) 
to LOS [68]. A survey of a collection of NTHi isolates 
detected lic1A in 96 % of the strains [45]; a later study from 
our laboratory on a panel of non-isogenic NTHi isolates of 
different pathological origin found a 100 % prevalence for 
lic1D [44]. PCho substitutions may occur on OSs extending 
from any Hep, depending on the lic1D allele (lic1DI, lic1DIII, 
lic1DIV), which encodes a diphosphonucleoside choline 
transferase [43,45]. Moreover, although most strains have a 
single lic1D gene, a survey of NTHi strains collected from 
the middle ear found that 16 % of them had two lic1D alleles, 
each in a separate, phase-variable lic1 locus, which together 
could result in two PCho substitutions in the LOS of the 
respective strain [21].
Available information on the heterogeneous distribution 
of additional genes involved in NTHi OS extensions, such 
as lpsA, lic2A, lgtC, and oafA, suggests that, although 
extensively present in NTHi strains [15,22,36,44], these 
genes are not necessarily conserved; for example, lic2A, lgtC 
and oafA are phase variable [15,22,32]. Moreover, allelic 
polymorphisms have been found in lpsA. This gene encodes 
a glycosyltransferase responsible for the addition of a Hex 
to HepIII; the added Hex can be either Glc or Gal, and Hep 
linkage can be either β 1-2 or β 1-3. Each H. infl uenzae 
strain produces only one of the four possible combinations 
of linked sugars in its LOS, due to a specifi c allelic variant 
of lpsA directing both linkage and the added Hex, Glc, or 
Gal [10]. Variable distribution, allelic polymorphisms, and 
phase-variable expression also characterize the lex2 locus. 
The lex2A gene contains a variable number of 5´-GCAA 
repeats; lex2B encodes the glucosyltransferase that adds the 
second Hex during the extension of LOS by HepI [28]. Allelic 
polymorphisms are assumed for lex2B, based on the alteration 
of a single amino acid in Lex2B, which correlates with the 
addition of Glc or Gal to the OS extension from HepI [9].
Variable distribution has also been evaluated on genes 
encoding adhesive molecules. Thus, the distribution of the 
adhesin-encoding genes hmw and hia in a panel of 59 non-
capsulated strains showed that 47 strains contained hmw1 
and hmw2 while nine strains contained hia, but no strain 
harbored both hmw and hia [63]. Based on the available evi-
dence: (i) all strains having hmw genes contain two hmw loci 
in conserved unlinked physical locations on the chromosome 
[5]; (ii) hmw genes occur in different allelic versions among 
strains [5,13]; and (iii) hmw genes are more prevalent in iso-
lates associated with acute OM than in the throat isolates of 
healthy children [14,39,73]. An additional source of diver-
sity is the phase variation of both hmw1A and hmw2A [8]. 
Although it has not been formally analyzed, hia may present 
polymorphisms, since its PCR amplifi cation in two panels of 
clinical strains rendered variable size products [17,59]. 
The prevalence of the phase-variable hifABCDE gene 
cluster, responsible for the biosynthesis of the hemaggluti-
nating pili, seems to be generally low [3,24], with a higher 
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prevalence among Hib than among NTHi isolates [14]. Dis-
crepancies among independent studies do not allow a clear 
association between anatomic isolation site (throat or middle 
ear) and hifABCDE distribution [14,64]. 
According to current information, the adhesin-encoding 
genes hap, ompP5, and oapA are universally distributed 
among noncapsulated isolates, but they display variation. Thus 
hap, encoding a self-associating autotransporter involved in 
intercellular aggregation [62], has a stop codon in strain Rd 
KW20, and its PCR amplifi cation results in products of differ-
ent sizes among clinical isolates (B. Euba, personal communi-
cation). The ompP5 gene, encoding an outer membrane pro-
tein involved in bacterial adhesion to host cell surfaces [34], is 
highly variable among strains [12,49]. Although its amplifi ca-
tion product was size-invariable among non-isogenic strains 
of different pathological origin, variability was detected in the 
fi ve extracellular loop domains predicted for P5 by PRED-
TMBB analysis [44]. Despite the heterogeneity of ompP5, a 
P5 sequence comparison in two separate isolate panels con-
taining sets of identical strains recovered from patients with 
a chronic respiratory disease who were seen in independent 
medical visits showed no differences among identical strains 
([49], A. López-Gómez, personal communication), pointing 
to the relative stability of P5 during NTHi persistence in the 
host. Conversely, the oapA amplifi cation product is size vari-
able, due to insertions/deletions in the gene region encoding 
the protein segment starting at amino acid 195 [44]. 
The iga gene, encoding an antigenically variable IgA1 
protease, is extensively distributed among strains [42].
However, compared to strains from other clinical sources, 
genomes of isolates from adults with COPD have a higher 
likelihood of also having igaB, encoding a second IgA1 
protease [52]. A sequence analysis of igaB showed minor 
sequence changes among isolates [52]. 
Collectively, variability studies based on a limited 
number of genes may facilitate associations between genes/
gene groups and disease manifestation or bacterial anatomic 
location, which in turn could reveal virulence factors and 
provide tools to predict virulence. However, gene selection, 
the number of selected genes, and the nature and size of the 
strain collections, are critical limiting factors that must be 
considered to obtain useful information. Comparative analysis 
of panels of whole-genome sequenced strains is a powerful 
approach that may contribute signifi cantly to overcome these 
limitations. 
Whole-genome multiple-strain sequencing. Se-
quenced strain Rd KW20 was useful in understanding the 
basic biology of H. infl uenzae, but it did not provide signifi -
cant insight into disease because is a rough derivative of H. 
infl uenzae serotype d, which is rarely disease-associated [31]. 
Nonetheless, the elucidation of differences between the ge-
nomes of strains isolated from disease states and the genome 
of strain Rd KW20 may yield insight into NTHi pathogenic-
ity. Thus, an analysis of NTHi strain 86-028NP, isolated from 
a patient with chronic OM, revealed large rearrangements in 
its genome architecture compared to strain Rd KW20, in ad-
dition to the presence of 280 ORFs not present in the latter 
strain [30]. Since then, further studies have provided increas-
ing information on the H. infl uenzae core- and pan-genome. A 
comparative genomic study of strain Rd KW20 and 12 NTHi 
clinical isolates identifi ed 2786 genes, of which 1461 were 
common to all strains. That study allowed the development of 
a fi nite supra-genome model in which a NTHi supra-genome 
containing between 4425 and 6052 genes was predicted [35]. 
A recent study sought to identify bacterial genetic elements 
with increased prevalence among strains isolated from COPD 
patients, compared to those from healthy carriers. Two NTHi 
strains recovered from the airways of two COPD patients and 
two strains from a healthy individual were sequenced. Seven 
genetic islands were defi ned, with their distribution among a 
panel of 421 strains of both disease and commensal origins re-
vealing that four of these islands were more prevalent in COPD 
than in colonizing strains [73]. Whole-genome sequencing 
on H. infl uenzae has also been applied to study the impact of 
transformation-mediated homologous recombination in inter-
strain exchange of DNA [46,57]. Indeed, H. infl uenzae ren-
dered the fi rst genome-wide analysis of chromosomes directly 
transformed with DNA from a divergent genotype [46].
Heterogeneity in gene expression and 
its contribution to NTHi strain stratifi -
cation
The presence or absence of a gene is not necessarily indicative 
of the infection outcome, as the same gene may be found in as-
ymptomatically carried strains but with slight genetic changes 
or differences in expression. NTHi differential gene expres-
sion has been mainly explored in phase-variable genes. The 
lic1ABCD operon is phase variably expressed due to a 5´-
CAAT repeat within the lic1A reading frame [68]. Differential 
PCho expression has been reported among NTHi isolates [44] 
and may vary depending on the anatomic location in the host. 
In fact, H. infl uenzae variable PCho expression may correlate 
with the ability of the bacterium to persist on the mucosal 
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surface (PCho+ phenotype), and to cause invasive infection 
by evading innate immunity mediated by acute-phase C-reac-
tive protein (PCho– phenotype) [67]. The losA gene is phase 
variably expressed due to a 5´-CGAGCATA repeat within the 
reading frame. Of 30 NTHi strains containing losA, 24 had 
two tandem copies of the SSR, allowing full-length transla-
tion of losA (on), and six had 3, 4, 6, or 10 tandem copies 
(losA off). The expression of losA, which is determined by 
the variations in its repeats, has been shown to affect NTHi 
resistance to serum-mediated killing [16].
Similarly, lic3A and lic3B, encoding two sialyltransfer-
ases, are phase variably expressed due to a 5´-CAAT repeat 
within their reading frames. The number of repeated motifs 
in 25 NTHi isolates was found to vary from 14 to 41 in lic3A 
and from 12 to 28 in lic3B; for both genes, two of the three 
possible reading frames were predicted to allow translation of 
full-length gene products from alternative initiation codons 
upstream of the repeats [20]. The lic2A galactosyltransferase-
encoding gene is variably expressed due to a 5´-CAAT repeat 
within its reading frame [32]. The number of repeated motifs 
within lic2A varied between 7 and 33 in a group of 19 NTHi 
isolates [44]. The repeated tract of lic2A is preceded by four 
putative initiation codons in two reading frames [11]. Fifteen 
of those 19 isolates contained an in-frame lic2A gene [44]. 
Independently, in an SSR analysis of lic2A using the above-
described panel of H. infl uenzae isolates collected from adult 
patients suffering an underlying chronic respiratory disease, 
the number of repeated motifs within lic2A in 28 of those 
isolates varied between 7 and 28. Sequence comparison from 
sets of identical strains recovered from the above-described 
group B patients demonstrated diversity in the number of 
lic2A repeats among identical strains over time. Digalactose 
has been linked to NTHi resistance to serum-mediated kill-
ing [15] and to virulence [27]. Evaluation of hmw1A and 
hmw2A gene expression in three NTHi invasive isolates and 
in the prototype strain 12 showed that increased numbers of 
5´-ATCTTTC repeats within the hmwA promoters correlate 
with decreased amounts of transcript [26]. In agreement with 
this fi nding, an analysis of HMW1 and HMW2 adhesins in 
isolates collected serially from COPD patients revealed that 
the expression of both proteins by a given strain decreased 
over time in the majority of patients, refl ecting a progressive 
increase in the numbers of 7-bp repeats [7].
Microarray studies comparing gene expression among 
isolates have provided evidence for a conserved core of genes 
preferentially expressed during H. infl uenzae growth in iron/
heme-restricted condition [69]. Differential expression of 
surface molecules between bacteria grown planktonically or 
forming biofi lms demonstrated a greater abundance of peroxi–
redoxin-glutaredoxin in H. infl uenzae biofi lms than in plank-
tonically grown bacteria. This molecule is involved in biofi lm 
formation by H. infl uenzae and the degree of its involvement 
varies among strains; note that peroxiredoxin-glutaredoxin is 
recognized by the human immune system in vivo, which sug-
gests its expression by H. infl uenzae during human respira-
tory tract infection [51]. LRT isolates associated with COPD 
exacerbation are more resistant to the bactericidal effect of se-
rum than colonizing isolates from the upper airway, with the 
expression of vacJ and yrb positively correlating with serum 
resistance. The vacJ gene functions with an ABC transporter 
encoded by yrb in the retrograde traffi cking of phospholipids 
from the outer to the inner leafl et of the cell envelope, sug-
gesting that NTHi adapts to infl ammation encountered during 
LRT infection by modulating its outer leafl et through the in-
creased expression of vacJ and yrb, thereby minimizing rec-
ognition by bactericidal anti-OS antibodies [53].
Collectively, existing data reinforce the notion that 
the heterogeneous expression of genes involved in NTHi 
virulence should be considered and integrated in studies of 
bacterial diversity, as this may be a useful basis for stratifying 
the virulence potential of clinical isolates and/or identifying 
potential therapeutic targets.
 
Variable phenotypes among NTHi iso-
lates and differential bacterial inter-
play with host immunity
Genetic traits may be ultimately of little interest unless they can 
be associated with virulence. However, a clear-cut relationship 
between virulence-linked genotype and phenotype remains 
elusive for NTHi. This gap could be due to: (i) the absence of 
clearly defi ned phenotypes that can differentiate among NTHi 
strains with and without virulence potential; (ii) the absence of 
systematic comparative phenotypic studies using a signifi cant 
number of isolates recovered from different disease states and 
from healthy carriers; and (iii) the lack of studies in which 
both genotypic and phenotypic traits are simultaneously 
analyzed in wide strain panels. 
An assessment of the phenotypic diversity of NTHi 
pointed out the differential interplay of host immunity 
elements and the various isolates. Variable resistance to 
serum-mediated killing among panels of NTHi isolates 
recovered from the pediatric inner ear and of non-isogenic 
NTHi isolates from different pathological origin suggested an 
association between LOS sialylation and NTHi resistance to 
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complement. This fi nding was supported by the high serum-
susceptibility displayed by a mutant strain lacking the CMP-
synthetase siaB gene [38,44]. In addition, serum resistance of 
losAB-containing strains has been correlated with an on-vs. 
off-state of losA [16]. However, an attempt to establish serum 
resistance as a virulence trait potentially shared by invasive 
noncapsulated H. infl uenzae strains did not render conclusive 
results [17]. Similarly, there was no clear difference in serum 
resistance or binding to complement inhibitors between 
invasive NTHi isolates obtained from patients with sepsis 
and nasopharyngeal strains obtained from patients with 
upper respiratory tract infection [29], although a signifi cant 
correlation between disease severity and serum resistance 
was identifi ed in cases of NTHi invasive disease [29].
Evidence points out that H. infl uenzae interplay with 
the respiratory epithelium involves bacterial adherence to 
epithelial cells and inter-bacterial interactions leading to 
microcolony formation. Microcolony formation may lead 
to the establishment of a biofi lm resistant to host immune 
factors. Attachment promotes bacterial invasion into epithelial 
cells, potentially providing a protected niche that may allow 
bacterial evasion from local immune mechanisms (Fig. 3). 
Adhesion to epithelial host cell surfaces [7,44] and biofi lm 
formation [50] are also heterogeneous features of NTHi. 
Of note, signifi cant phenotypic differences between NTHi 
strains from COPD exacerbation and colonizers have been 
reported, with the former strains having greater adherence 
to airway epithelial cells and inducing more severe airway 
infl ammation [6]. Another variable phenotypic trait is the 
antigenic variability of surface-exposed epitopes, evidenced 
by the development of new highly strain-specifi c bactericidal 
antibodies after exacerbation; these antibodies show low 
bactericidal activity for heterologous strains [61]. 
While a signifi cant correlation between disease pheno-
type and global comparative genomic data would facilitate 
the stratifi cation of isolates and our ability to predict disease 
manifestations, this goal remains elusive. In an in vivo chin-
chilla model of OM aimed at characterizing the local and sys-
temic virulence patterns of ten genomically analyzed NTHi 
isolates from children with chronic OM with effusion or with 
otorrhea, strain stratifi cation was indeed possible, but global 
comparative genomics of the same strains did not cluster them 
Fig. 3. Model presenting key features of epithelial cell infection by Haemophilus infl uenzae. Bacteria adhere to the cell surface. Once bacteria have adhered, inter-
bacterial interactions lead to microcolony formation. Microcolony formation facilitates bacterial invasion into epithelial cells, potentially providing a protected 
niche and allowing bacterial evasion of host immunity. Rigth: a scanning electron micrograph shows NTHi infection of A549 immortalized human type II pneu-
mocytes; the white arrows point at the attachment of bacteria to the host cell surface. Image courtesy of Dr. José Ramos Vivas, Fundación Marqués de Valdecilla, 
Santander, Spain.
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by clinical phenotype [4]. Although several reasons could 
explain this inaccuracy, the wide genetic diversity among 
strains is particularly probable, given that genome sequence 
comparison has shown that the mean number of gene differ-
ences among each of the possible strain pairs are >350, but the 
number of genes associated with each parameter of clinical 
virulence may be a small fraction thereof [4]. 
In summary, the wide genetic and phenotypic variability 
among NTHi strains highlights the need to explore alternative 
approaches to facilitate the association of genotype with 
phenotype. 
Current questions and challenges for 
future studies on the diversity of non-
capsulated Haemophilus  infl uenzae 
Pathogenicity is the result of the relationship between a 
bacterium and its host, specifi cally, between bacterial virulence 
factors, including how and when they are expressed, and 
the host immune status. The latter is determined by genetic 
factors, age, lifestyle, co-infections, and exposure to external 
agents, all of which can modulate host physiology and the 
ability to fi ght infection.
Host factors in the dynamics of NTHi infec-
tion. Defi ning the role of host immunity in disease outcome 
is crucial; indeed, pathogen diversity studies should ideally 
be conducted in parallel with immunological studies on the 
respective host. This aspect may be particularly crucial for 
highly adapted and very fl exible opportunistic pathogens such 
as H. infl uenzae, for which host immunological status is a 
strong determinant in the ability of a pathogen to cause symp-
tomatic disease in a previously asymptomatic healthy carrier. 
An example of this notion is the association between 
NTHi infection and the progression of COPD. Patients with 
COPD sufffer from chronic bronchitis, emphysema, or both. 
In these diseases, the airways become narrowed, which leads 
to an irreversible limitation of airfl ow to and from the lungs, 
causing shortness of breath [2]. COPD is caused by airway 
exposure to noxious particles or gas, most commonly from 
tobacco smoking, which triggers an abnormal infl ammatory 
response in the lung. These deleterious agents impair normal 
respiratory function and alter the host’s response to infection 
by opportunistic pathogens such as NTHi, which colonizes the 
upper airways, causes chronic LRT infection, and is frequently 
isolated in disease exacerbation [23]. Prospective comparative 
genotype and phenotype analyses of multiple NTHi isolates 
serially recovered from the upper and lower airways of COPD 
patients in stable and acute condition, together with detailed 
clinical, infl ammatory, and patho-physiological information 
obtained from those patients at the time of each microbial 
isolation, would provide invaluable biological material and 
information with which to assess microbial evolution. It 
would also faciliate the design of tools to predict disease 
severity, the virulence potential of a bacterial strain, and the 
outcome of the host-pathogen encounter. 
Virulence vs. niche factors and NTHi adaptation 
vs. infection. Given that NTHi is highly adapted to the 
human respiratory microbiota, it is likely to be equipped 
with evasion strategies allowing the bacterium to endlessly 
colonize the host. Evidence demonstrating differential gene 
distribution between strains isolated from different body 
locations and/or disease states supports the existence of 
genetic traits associated with disease [73]. However, an 
increase in the number, size, and clinical and geographical 
diversity of the strain panels screened may dilute the relevance 
of those proposed genetic virulence traits due to their 
extensive presence in healthy carrier isolates. Instead, they 
may prompt us to consider the fi ne line between virulence, 
adaptation, and genetic fi tness for NTHi. This consideration 
should not limit the potential of currently identifi ed genetic 
virulence traits, which could well be involved in both the 
colonization of healthy hosts and the symptomatic infection 
of immunocompromised individuals. In fact, many structures 
and strategies playing important roles in establishing and 
maintaining infection have been discovered and characterized 
in pathogens. However, these virulence factors can also be 
shared by commensals because they are required for their 
existence in the host, thus suggesting their re-consideration 
as niche factors [33].
Our current understanding of the role of NTHi virulence 
factors is in part based on lack-of-function mutant strains 
generated in the laboratory, when assayed for phenotypes 
linked to virulence. This approach, essential for gene–
function associations, nonetheless has certain risks that must 
be taken into account in any discussion of the resulting data, 
given that: (i) there is often a reliance on reference strains 
that can be mutated under laboratory conditions, which can 
generate strain-dependent bias; (ii) functional redundancy 
is frequently not considered, although it could be a source 
of bias in the form of single-mutant strain-dependent data. 
Moreover, the relevance of so-called virulence phenotypes 
in the refi ned adaptation and colonization of the human host 
by NTHi cannot be excluded. Indeed, for NTHi, the precise 
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defi nition of phenotypes that clearly differentiate virulent and 
colonizing strains may be risky, as the difference may actually 
depend on host status. Further experimental evidence is 
required to address these issues. The widest possible repertoire 
of virulence phenotypes should be systematically assayed on 
vast collections of genotypically characterized NTHi strains, 
recovered from healthy carriers and from different disease 
states, in order to cluster phenotypes into categories and to 
defi ne virulence and/or adaptation indexes.
The challenges of genomic information in the 
study of NTHi diversity. In general, comparative 
genomics of microbial pathogens aims to predict the virulence 
potential of a bacterial strain from its genome sequence [58]. 
Sequencing can identify which virulence factor-encoding 
genes are present in a genome. However, the presence of 
these genes in itself is not indicative of disease outcome, 
as the same gene might well be found in asymptomatically 
carried strains. Therefore, without an understanding of 
the regulatory and epistatic processes controlling gene 
expression, the contribution of a list of genes to virulence 
cannot be quantifi ed. A systems biology approach based on a 
comprehensive understanding of the combinations of genetic 
backgrounds, regulatory networks, and virulence factors that 
produce virulent strains has been proposed to help researchers 
determine the propensity of a particular strain to cause disease.
The goals of the proposed framework are: (i) to defi ne 
phenotypes that differentiate virulent and avirulent strains; 
(ii) to characterize how the relevant phenotypes are encoded, 
using expression arrays to construct models of the gene-
regulatory networks as well as process diagrams informed by 
the underlying genetics; (iii) to develop models that predict the 
gene combinations leading to specifi c virulence phenotypes; 
and (iv) to test and refi ne the models with sets of strains 
independent from those used to build the model [58]. Although 
tailored to Staphylococcus aureus, mounting information on 
H. infl uenzae diversity may provide the necessary conditions 
to apply this type of framework to the prediction of virulence 
phenotypes using H. infl uenzae genome sequences.
Laboratory experiments have led to important fi ndings 
relating organism adaptation to genomic evolution. 
Continuous monitoring of long-term evolution in natural 
systems is expanding our knowledge of these processes in 
situ. We highlight here two exemples. Thus, the evolutionary 
dynamics of a lineage of Pseudomonas aeruginosa as it 
adapted to the airways of several individual CF patients over 
200,000 bacterial generations has been reported. In contrast 
to predictions based on in vitro evolution experiments, the 
evolving lineage showed limited diversifi cation, in which an 
initial period of rapid adaptation caused by a small number of 
mutations with pleiotropic effects was followed by a period of 
genetic drift with limited phenotypic change and a genomic 
signature of negative selection. This pattern suggests that 
the evolving lineage reached a major adaptive peak in the 
fi tness landscape [72]. Independently, in a retrospective study 
of a Burkholderia dolosa outbreak among CF patients, the 
genomes of 112 isolates collected from 14 individuals over 
16 years were sequenced. Seventeen of the bacterial genes 
had acquired non-synonymous mutations that were detected 
in multiple individuals, indicating parallel adaptive evolution. 
Importantly, these mutations shed light on the genetic basis of 
pathogenic phenotypes [40]. NTHi acute and chronic infection 
has been associated with the progression of cigarette-smoke-
related diseases such as COPD, which suggests the ability of 
this pathogen to adapt to a human niche rich in free radicals 
and other aromatic compounds present in smoke. This type 
of disease state offers a unique natural system for continuous 
monitoring of the long-term evolution of H. infl uenzae in the 
upper and lower airways of humans. 
Final remarks
Its relatively small genome size and wide genetic plasticity, 
together with its asymptomatic colonizer–virulence duality and 
prominent association with chronic respiratory diseases make 
noncapsulated H. infl uenzae a unique bacterial system for studies 
of microbial adaptation, pathogenesis, and long-term microbial 
evolution in human hosts exposed to external deleterious agents. 
Access to comprehensive strain panels and detailed clinical 
data from the respective hosts, when combined with extensive 
whole-genome sequencing and systematic phenotypic analysis 
in large number of isolates, will provide extensive insights into 
NTHi pathogenesis as well as both the tools to predict virulence 
and information on bacterial evolution and adaptation. Now 
that microbial whole-genome sequencing is becoming routine 
in diagnostic and public-health microbiology, this may be the 
right time to tackle detailed studies of the opportunistic pathogen 
nontypable H. infl uenzae.
Acknowledgements. We thank Drs. Cristina Prat (Germans Trias i 
Pujol Hospital) and Josefi na Liñares (University Hospital Bellvitge) for 
providing strains, Dr. Laura Calatayud for helping with PFGE and clinical 
data, and Dr. Pau Morey for helpful reading of the manuscript. This work 
has been funded by grants from the Health Institute Carlos III (ISCIII), grant 
PI09/00130, and from the Health Department of the Government of  Navarra, 
Spain (Call 2011) to J.G., and by grant PI09/01904 (ISCIII) to J. Liñares. 
CIBERES is an initiative from ISCIII, Spain.
INT. MICROBIOL. Vol. 15, 2012 GARMENDIA ET AL.168
Competing interest. None declared.
References
1.  Agrawal A, Murphy TF (2011) Haemophilus infl uenzae infections 
in the H. infl uenzae type b conjugate vaccine era. J Clin Microbiol 
49:3728-3732
2. Barnes PJ (2004) Mediators of chronic obstructive pulmonary disease. 
Pharmacol Rev 56:515-548
3. Bayliss CD, Sweetman WA, Moxon ER (2004) Mutations in Haemophilus 
infl uenzae mismatch repair genes increase mutation rates of dinucleotide 
repeat tracts but not dinucleotide repeat-driven pilin phase variation 
rates. J Bacteriol 186:2928-2935
4. Buchinsky FJ, Forbes ML, Hayes JD, Shen K, Ezzo S, Compliment 
J, Hogg J, Hiller NL, Hu FZ, Post JC, Ehrlich GD (2007) Virulence 
phenotypes of low-passage clinical isolates of nontypeable Haemophilus 
infl uenzae assessed using the chinchilla laniger model of otitis media. 
BMC Microbiol 7:56
5. Buscher AZ, Burmeister K, Barenkamp SJ, St Geme JW 3rd (2004) 
Evolutionary and functional relationships among the nontypeable 
Haemophilus infl uenzae HMW family of adhesins. J Bacteriol 
186:4209-4217
6. Chin CL, Manzel LJ, Lehman EE, Humlicek AL, Shi L, Starner TD, 
Denning GM, Murphy TF, Sethi S, Look DC (2005) Haemophilus 
infl uenzae from patients with chronic obstructive pulmonary disease 
exacerbation induce more infl ammation than colonizers. Am J Respir 
Crit Care Med 172:85-91
7. Cholon DM, Cutter D, Richardson SK, Sethi S, Murphy TF, Look 
DC, St Geme JW 3rd (2008) Serial isolates of persistent Haemophilus 
infl uenzae in patients with chronic obstructive pulmonary disease 
express diminishing quantities of the HMW1 and HMW2 adhesins. 
Infect Immun 76:4463-4468
8. Dawid S, Barenkamp SJ, St Geme JW 3rd (1999) Variation in expression 
of the Haemophilus infl uenzae HMW adhesins: a prokaryotic system 
reminiscent of eukaryotes. Proc Natl Acad Sci USA 96:1077-1082
9. Deadman ME, Hermant P, Engskog M, Makepeace K, Moxon 
ER, Schweda EK, Hood DW (2009) Lex2B, a phase-variable 
glycosyltransferase, adds either a glucose or a galactose to Haemophilus 
infl uenzae lipopolysaccharide. Infect Immun 77:2376-2384
10. Deadman ME, Lundstrom SL, Schweda EK, Moxon ER, Hood DW 
(2006) Specifi c amino acids of the glycosyltransferase LpsA direct the 
addition of glucose or galactose to the terminal inner core heptose of 
Haemophilus infl uenzae lipopolysaccharide via alternative linkages. 
J Biol Chem 281:29455-29467
11. Dixon K, Bayliss CD, Makepeace K, Moxon ER, Hood DW (2007) 
Identifi cation of the functional initiation codons of a phase-variable 
gene of Haemophilus infl uenzae, lic2A, with the potential for differential 
expression. J Bacteriol 189:511-521
12. Duim B, Bowler LD, Eijk PP, Jansen HM, Dankert J, van Alphen L 
(1997) Molecular variation in the major outer membrane protein P5 gene 
of nonencapsulated Haemophilus infl uenzae during chronic infections. 
Infect Immun 65:1351-1356
13. Ecevit IZ, McCrea KW, Marrs CF, Gilsdorf JR (2005) Identifi cation of 
new hmwA alleles from nontypeable Haemophilus infl uenzae. Infect 
Immun 73:1221-1225
14. Ecevit IZ, McCrea KW, Pettigrew MM, Sen A, Marrs CF, Gilsdorf JR 
(2004) Prevalence of the hifBC, hmw1A, hmw2A, hmwC, and hia genes 
in Haemophilus infl uenzae isolates. J Clin Microbiol 42:3065-3072
15. Erwin AL, Allen S, Ho DK, Bonthuis PJ, Jarisch J, Nelson KL, Tsao DL, 
Unrath WC, Watson ME Jr., Gibson BW, Apicella MA, Smith AL (2006) 
Role of lgtC in resistance of nontypeable Haemophilus infl uenzae strain 
R2866 to human serum. Infect Immun 74:6226-6235
16. Erwin AL, Bonthuis PJ, Geelhood JL, Nelson KL, McCrea KW, Gilsdorf 
JR, Smith AL (2006) Heterogeneity in tandem octanucleotides within 
Haemophilus infl uenzae lipopolysaccharide biosynthetic gene losA 
affects serum resistance. Infect Immun 74:3408-3414
17. Erwin AL, Nelson KL, Mhlanga-Mutangadura T, et al. (2005) 
Characterization of genetic and phenotypic diversity of invasive 
nontypeable Haemophilus infl uenzae. Infect Immun 73:5853-5863
18. Farjo RS, Foxman B, Patel MJ, Zhang L, Pettigrew MM, McCoy SI, 
Marrs CF, Gilsdorf JR (2004) Diversity and sharing of Haemophilus 
infl uenzae strains colonizing healthy children attending day-care centers. 
Pediatr Infect Dis J 23:41-46
19. Fleischmann RD, Adams MD, White O, et al. (1995) Whole-genome 
random sequencing and assembly of Haemophilus infl uenzae Rd. 
Science 269:496-512
20. Fox KL, Cox AD, Gilbert M, Wakarchuk WW, Li J, Makepeace K, 
Richards JC, Moxon ER, Hood DW (2006) Identifi cation of a bifunctional 
lipopolysaccharide sialyltransferase in Haemophilus infl uenzae: 
incorporation of disialic acid. J Biol Chem 281:40024-40032
21. Fox KL, Li J, Schweda EK, Vitiazeva V, Makepeace K, Jennings MP, 
Moxon ER, Hood DW (2008) Duplicate copies of lic1 direct the addition of 
multiple phosphocholine residues in the lipopolysaccharide of Haemophilus 
infl uenzae. Infect Immun 76:588-600
22. Fox KL, Yildirim HH, Deadman ME, Schweda EK, Moxon ER, Hood 
DW (2005) Novel lipopolysaccharide biosynthetic genes containing 
tetranucleotide repeats in Haemophilus infl uenzae, identifi cation of a 
gene for adding O-acetyl groups. Mol Microbiol 58:207-216
23. Garmendia J, Morey P, Bengoechea JA (2012) Impact of cigarette 
smoke exposure on host-bacterial pathogen interactions. Eur Respir J 
39:467-477
24. Geluk F, Eijk PP, van Ham SM, Jansen HM, van Alphen L (1998) The 
fi mbria gene cluster of nonencapsulated Haemophilus infl uenzae. Infect 
Immun 66:406-417
25. Gilsdorf JR, Marrs CF, Foxman B (2004) Haemophilus infl uenzae: 
genetic variability and natural selection to identify virulence factors. 
Infect Immun 72:2457-2461
26. Giufre M, Carattoli A, Cardines R, Mastrantonio P, Cerquetti M (2008) 
Variation in expression of HMW1 and HMW2 adhesins in invasive 
nontypeable Haemophilus infl uenzae isolates. BMC Microbiol 8:83
27. Griffi n R, Bayliss CD, Herbert MA, Cox AD, Makepeace K, Richards 
JC, Hood DW, Moxon ER (2005) Digalactoside expression in 
the lipopolysaccharide of Haemophilus infl uenzae and its role in 
intravascular survival. Infect Immun 73:7022-7026
28. Griffi n R, Cox AD, Makepeace K, Richards JC, Moxon ER, Hood DW 
(2003) The role of lex2 in lipopolysaccharide biosynthesis in Haemophilus 
infl uenzae strains RM7004 and RM153. Microbiology 149:3165-3175
29. Hallstrom T, Resman F, Ristovski M, Riesbeck K (2010) Binding of 
complement regulators to invasive nontypeable Haemophilus infl uenzae 
isolates is not increased compared to nasopharyngeal isolates, but serum 
resistance is linked to disease severity. J Clin Microbiol 48:921-927
30. Harrison A, Dyer DW, Gillaspy A, Ray WC, Mungur R, Carson MB, 
Zhong H, Gipson J, Gipson M, Johnson LS, Lewis L, Bakaletz LO, 
Munson RS, Jr. (2005) Genomic sequence of an otitis media isolate 
of nontypeable Haemophilus infl uenzae: comparative study with H. 
infl uenzae serotype d, strain KW20. J Bacteriol 187:4627-4636
31. Heath PT, Booy R, Azzopardi HJ, Slack MP, Fogarty J, Moloney AC, 
Ramsay ME, Moxon ER (2001) Non-type b Haemophilus infl uenzae 
disease: clinical and epidemiologic characteristics in the Haemophilus 
infl uenzae type b vaccine era. Pediatr Infect Dis J 20:300-305
INT. MICROBIOL. Vol. 15, 2012DIVERSITY OF NONCAPSULATED H. INFLUENZAE 169
32. High NJ, Jennings MP, Moxon ER (1996) Tandem repeats of the 
tetramer 5′-CAAT-3′ present in lic2A are required for phase variation 
but not lipopolysaccharide biosynthesis in Haemophilus infl uenzae. Mol 
Microbiol 20:165-174
33. Hill C (2012) Virulence or niche factors: what’s in a name? J Bacteriol 
194:5725-5727
34. Hill DJ, Toleman MA, Evans DJ, Villullas S, Van Alphen L, Virji M (2001) 
The variable P5 proteins of typeable and non-typeable Haemophilus 
infl uenzae target human CEACAM1. Mol Microbiol 39:850-862
35. Hogg JS, Hu FZ, Janto B, Boissy R, Hayes J, Keefe R, Post JC, Ehrlich 
GD (2007) Characterization and modeling of the Haemophilus infl uenzae 
core and supragenomes based on the complete genomic sequences of Rd 
and 12 clinical nontypeable strains. Genome Biol 8:R103
36. Hood DW, Deadman ME, Cox AD, Makepeace K, Martin A, Richards 
JC, Moxon ER (2004) Three genes, lgtF, lic2C and lpsA, have a primary 
role in determining the pattern of oligosaccharide extension from the 
inner core of Haemophilus infl uenzae LPS. Microbiology 150:2089-2097
37. Hood DW, Deadman ME, Engskog MK, Vitiazeva V, Makepeace K, 
Schweda EK, Moxon R (2010) Genes required for the synthesis of 
heptose-containing oligosaccharide outer core extensions in Haemophilus 
infl uenzae lipopolysaccharide. Microbiology 156:3421-3431
38. Hood DW, Makepeace K, Deadman ME, Rest RF, Thibault P, Martin 
A, Richards JC, Moxon ER (1999) Sialic acid in the lipopolysaccharide 
of Haemophilus infl uenzae: strain distribution, infl uence on serum 
resistance and structural characterization. Mol Microbiol 33:679-692
39. Krasan GP, Cutter D, Block SL, St Geme JW 3rd (1999) Adhesin 
expression in matched nasopharyngeal and middle ear isolates of 
nontypeable Haemophilus infl uenzae from children with acute otitis 
media. Infect Immun 67:449-454
40. Lieberman TD, Michel JB, Aingaran M, Potter-Bynoe G, Roux D, 
Davis MR, Jr., Skurnik D, Leiby N, LiPuma JJ, Goldberg JB, McAdam 
AJ, Priebe GP, Kishony R (2011) Parallel bacterial evolution within 
multiple patients identifi es candidate pathogenicity genes. Nat Genet 
43:1275-1280
41. Lijek RS, Weiser JN (2012) Co-infection subverts mucosal immunity in 
the upper respiratory tract. Curr Opin Immunol 24:417-423
42. Lomholt H, van Alphen L, Kilian M (1993) Antigenic variation of 
immunoglobulin A1 proteases among sequential isolates of Haemophilus 
infl uenzae from healthy children and patients with chronic obstructive 
pulmonary disease. Infect Immun 61:4575-4581
43. Lysenko E, Richards JC, Cox AD, Stewart A, Martin A, Kapoor M, Weiser 
JN (2000) The position of phosphorylcholine on the lipopolysaccharide 
of Haemophilus infl uenzae affects binding and sensitivity to C-reactive 
protein-mediated killing. Mol Microbiol 35:234-245
44. Martí-Lliteras P, López-Gómez A, Mauro S, Hood DW, Viadas C, 
Calatayud L, Morey P, Servin A, Linares J, Oliver A, Bengoechea JA, 
Garmendia J (2011) Nontypable Haemophilus infl uenzae displays a 
prevalent surface structure molecular pattern in clinical isolates. PLoS 
One 6:e21133
45. McCrea KW, Xie J, LaCross N, Patel M, Mukundan D, Murphy TF, 
Marrs CF, Gilsdorf JR (2008) Relationships of nontypeable Haemophilus 
infl uenzae strains to hemolytic and nonhemolytic Haemophilus 
haemolyticus strains. J Clin Microbiol 46:406-416
46. Mell JC, Shumilina S, Hall IM, Redfi eld RJ (2011) Transformation of 
natural genetic variation into Haemophilus infl uenzae genomes. PLoS 
Pathog 7:e1002151
47. Mira A, Martin-Cuadrado AB, D’Auria G, Rodriguez-Valera F (2010) 
The bacterial pan-genome: a new paradigm in microbiology. Int 
Microbiol 13:45-57
48. Moxon R, Bayliss C, Hood D (2006) Bacterial contingency loci: the 
role of simple sequence DNA repeats in bacterial adaptation. Annu Rev 
Genet 40:307-333
49. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S (2004) Persistent 
colonization by Haemophilus infl uenzae in chronic obstructive 
pulmonary disease. Am J Respir Crit Care Med 170:266-272
50. Murphy TF, Kirkham C (2002) Biofi lm formation by nontypeable 
Haemophilus infl uenzae: strain variability, outer membrane antigen 
expression and role of pili. BMC Microbiol 2:7
51. Murphy TF, Kirkham C, Sethi S, Lesse AJ (2005) Expression of a 
peroxiredoxin-glutaredoxin by Haemophilus infl uenzae in biofi lms and 
during human respiratory tract infection. FEMS Immunol Med Microbiol 
44:81-89
52. Murphy TF, Lesse AJ, Kirkham C, Zhong H, Sethi S, Munson RS Jr. 
(2011) A clonal group of nontypeable Haemophilus infl uenzae with two 
IgA proteases is adapted to infection in chronic obstructive pulmonary 
disease. PLoS One 6:e25923
53. Nakamura S, Shchepetov M, Dalia AB, Clark SE, Murphy TF, Sethi S, 
Gilsdorf JR, Smith AL, Weiser JN (2011) Molecular basis of increased 
serum resistance among pulmonary isolates of non-typeable Haemophilus 
infl uenzae. PLoS Pathog 7:e1001247
54. Oliver A, Mena A (2010) Bacterial hypermutation in cystic fi brosis, not 
only for antibiotic resistance. Clin Microbiol Infect 16:798-808
55. Pettigrew MM, Foxman B, Marrs CF, Gilsdorf JR (2002) Identifi cation 
of the lipooligosaccharide biosynthesis gene lic2B as a putative virulence 
factor in strains of nontypeable Haemophilus infl uenzae that cause otitis 
media. Infect Immun 70:3551-3556
56. Poje G, Redfi eld RJ (2003) Transformation of Haemophilus infl uenzae. 
Methods Mol Med 71:57-70
57. Power PM, Bentley SD, Parkhill J, Moxon ER, Hood DW (2012) 
Investigations into genome diversity of Haemophilus infl uenzae 
using whole genome sequencing of clinical isolates and laboratory 
transformants. BMC Microbiol 12:273
58. Priest NK, Rudkin JK, Feil EJ, van den Elsen JM, Cheung A, Peacock 
SJ, Laabei M, Lucks DA, Recker M, Massey RC (2012) From genotype 
to phenotype: can systems biology be used to predict Staphylococcus 
aureus virulence? Nat Rev Microbiol 10:791-797
59. Rodriguez CA, Avadhanula V, Buscher A, Smith AL, St Geme JW 
3rd, Adderson EE (2003) Prevalence and distribution of adhesins in 
invasive non-type b encapsulated Haemophilus infl uenzae. Infect Immun 
71:1635-1642
60. Schweda EK, Richards JC, Hood DW, Moxon ER (2007) Expression and 
structural diversity of the lipopolysaccharide of Haemophilus infl uenzae: 
implication in virulence. Int J Med Microbiol 297:297-306
61. Sethi S, Wrona C, Grant BJ, Murphy TF (2004) Strain-specifi c immune 
response to Haemophilus infl uenzae in chronic obstructive pulmonary 
disease. Am J Respir Crit Care Med 169:448-453
62. Spahich NA, St Geme JW 3rd (2011) Structure and function of the 
Haemophilus infl uenzae autotransporters. Front Cell Infect Microbiol 1:5
63. St Geme JW 3rd, Kumar VV, Cutter D, Barenkamp SJ (1998) Prevalence 
and distribution of the hmw and hia genes and the HMW and Hia 
adhesins among genetically diverse strains of nontypeable Haemophilus 
infl uenzae. Infect Immun 66:364-368
64. Syed SS, Gilsdorf JR (2007) Prevalence of hicAB, lav, traA, and hifBC 
among Haemophilus infl uenzae middle ear and throat strains. FEMS 
Microbiol Lett 274:180-183
65. Twelkmeyer B, Deadman ME, Haque E, Li J, Hood DW, Schweda 
EK (2011) The role of lic2B in lipopolysaccharide biosynthesis in 
Haemophilus influenzae strain Eagan. Carbohydr Res 346:1262-
1266
66. Weimer KE, Armbruster CE, Juneau RA, Hong W, Pang B, Swords 
WE (2010) Coinfection with Haemophilus infl uenzae promotes 
pneumococcal biofi lm formation during experimental otitis media 
and impedes the progression of pneumococcal disease. J Infect Dis 
202:1068-1075
INT. MICROBIOL. Vol. 15, 2012 GARMENDIA ET AL.170
67 Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J (1998) 
Phosphorylcholine on the lipopolysaccharide of Haemophilus infl uenzae 
contributes to persistence in the respiratory tract and sensitivity to serum 
killing mediated by C-reactive protein. J Exp Med 187:631-640
68. Weiser JN, Shchepetov M, Chong ST (1997) Decoration of lipopolysac-
charide with phosphorylcholine: a phase-variable characteristic of Hae-
mophilus infl uenzae. Infect Immun 65:943-950
69. Whitby PW, Seale TW, VanWagoner TM, Morton DJ, Stull TL (2009) 
The iron/heme regulated genes of Haemophilus infl uenzae: comparative 
transcriptional profi ling as a tool to defi ne the species core modulon. 
BMC Genomics 10:6
70. Wild CP (2012) The exposome: from concept to utility. Int J Epidemiol 
41:24-32
71. Xie J, Juliao PC, Gilsdorf JR, Ghosh D, Patel M, Marrs CF (2006) 
Identifi cation of new genetic regions more prevalent in nontypeable 
Haemophilus infl uenzae otitis media strains than in throat strains. J Clin 
Microbiol 44:4316-4325
72. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, 
Hansen SK, Folkesson A, Johansen HK, Ciofu O, Hoiby N, Sommer 
MO, Molin S (2011) Evolutionary dynamics of bacteria in a human host 
environment. Proc Natl Acad Sci USA 108:7481-7486
73. Zhang L, Xie J, Patel M, Bakhtyar A, Ehrlich GD, Ahmed A, Earl J, 
Marrs CF, Clemans D, Murphy TF, Gilsdorf JR (2012) Nontypeable 
Haemophilus infl uenzae genetic islands associated with chronic 
pulmonary infection. PLoS One 7:e44730
